oseltamivir has been researched along with Aspergillosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brock, M; Fremau, A; Humblet-Baron, S; Jacobs, C; Laeveren, B; Lagrou, K; Naesens, L; Ostyn, T; Reséndiz-Sharpe, A; Seldeslachts, L; Van De Veerdonk, FL; Vande Velde, G; Vanderbeke, L; Verbeken, E; Wauters, J | 1 |
| Helbig, G; Kyrcz-Krzemien, S; Pająk, J; Wieczorkiewicz, A; Woźniczka, K | 1 |
2 other study(ies) available for oseltamivir and Aspergillosis
| Article | Year |
|---|---|
Early oseltamivir reduces risk for influenza-associated aspergillosis in a double-hit murine model.
Topics: Animals; Aspergillosis; Aspergillus; Aspergillus fumigatus; Coinfection; Disease Models, Animal; Humans; Influenza, Human; Invasive Pulmonary Aspergillosis; Mice; Oseltamivir; Pulmonary Aspergillosis; X-Ray Microtomography | 2021 |
Irreversible marrow aplasia after single course of 2-chlorodeoxyadenosine for hairy cell leukaemia preceding by A pandemic 2009-H1N1-associated pneumonia.
Topics: Amoxicillin; Anemia, Aplastic; Anti-Infective Agents; Antineoplastic Agents; Antiviral Agents; Aspergillosis; Bone Marrow; Ciprofloxacin; Cladribine; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Leukemia, Hairy Cell; Male; Oseltamivir; Pancytopenia; Pandemics; Pneumonia, Viral; Young Adult | 2011 |